Bradley Canino
Analyst
Guggenheim
Equibles does not estimate personal net worth.
About Bradley Canino
Bradley Canino is recorded as Analyst at Guggenheim. Bradley Canino has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Bicara Therapeutics Inc. on August 11, 2026. Those appearances were for Bicara Therapeutics Inc. (BCAX), Celcuity Inc. (CELC) and Relay Therapeutics, Inc. (RLAY). The companies whose calls Bradley Canino spoke on are classified in the Healthcare sector.
Bradley Canino on recent calls
“Well, it's definitely rare you get to congratulate so many people at once, so it's great to see the continuity for the company as well. Two check-in questions for me.”
“Now that we have the data, maybe some commercial questions. I guess with this profile, what do you think GEDIC can achieve in the PIC3C and Mutant subgroup? Annualized cappy sales look to be about $700 million in the U.S. geography, if I've got that right.”
“Can we just double-click on the prior question with some more details about how you believe whether you are or are leaving efficacy on the table by not bringing forward the 400-MIG BID oncology dose?”
Affiliation history
-
Guggenheim
Analyst
Transcript header (unverified)
Current
Company network
Celcuity Inc.
CELC
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-06-02
View calls and events